Researchers are excited about the medication , a novel dual compound showing remarkable outcomes in early trials for size reduction . It functions by targeting two pathways : GLP-1 and GIP, these, when https://janicewdwf248702.anchor-blog.com/21177676/the-new-prospect-for-size-management